NeuroLux, an early stage biotech company based in Champaign, IL, has been awarded a Small Business Technology Transfer (STTR) Phase I grant by the National Institutes of Health (NIH) to develop wireless, battery-free devices for programmable fluid delivery and optogenetic stimulation, in designs fully compatible with the existing NeuroLux HF...
